XOMA Corp
NASDAQ:XOMA

Watchlist Manager
XOMA Corp Logo
XOMA Corp
NASDAQ:XOMA
Watchlist
Price: 31.26 USD 0.32% Market Closed
Market Cap: 365.7m USD
Have any thoughts about
XOMA Corp?
Write Note

Intrinsic Value

The intrinsic value of one XOMA stock under the Base Case scenario is 35.65 USD. Compared to the current market price of 31.26 USD, XOMA Corp is Undervalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

XOMA Intrinsic Value
35.65 USD
Undervaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
XOMA Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for XOMA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about XOMA?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about XOMA Corp

Provide an overview of the primary business activities
of XOMA Corp.

What unique competitive advantages
does XOMA Corp hold over its rivals?

What risks and challenges
does XOMA Corp face in the near future?

Has there been any significant insider trading activity
in XOMA Corp recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for XOMA Corp.

Provide P/S
for XOMA Corp.

Provide P/E
for XOMA Corp.

Provide P/OCF
for XOMA Corp.

Provide P/FCFE
for XOMA Corp.

Provide P/B
for XOMA Corp.

Provide EV/S
for XOMA Corp.

Provide EV/GP
for XOMA Corp.

Provide EV/EBITDA
for XOMA Corp.

Provide EV/EBIT
for XOMA Corp.

Provide EV/OCF
for XOMA Corp.

Provide EV/FCFF
for XOMA Corp.

Provide EV/IC
for XOMA Corp.

Show me price targets
for XOMA Corp made by professional analysts.

What are the Revenue projections
for XOMA Corp?

How accurate were the past Revenue estimates
for XOMA Corp?

What are the Net Income projections
for XOMA Corp?

How accurate were the past Net Income estimates
for XOMA Corp?

What are the EPS projections
for XOMA Corp?

How accurate were the past EPS estimates
for XOMA Corp?

What are the EBIT projections
for XOMA Corp?

How accurate were the past EBIT estimates
for XOMA Corp?

Compare the revenue forecasts
for XOMA Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of XOMA Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of XOMA Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of XOMA Corp compared to its peers.

Compare the P/E ratios
of XOMA Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing XOMA Corp with its peers.

Analyze the financial leverage
of XOMA Corp compared to its main competitors.

Show all profitability ratios
for XOMA Corp.

Provide ROE
for XOMA Corp.

Provide ROA
for XOMA Corp.

Provide ROIC
for XOMA Corp.

Provide ROCE
for XOMA Corp.

Provide Gross Margin
for XOMA Corp.

Provide Operating Margin
for XOMA Corp.

Provide Net Margin
for XOMA Corp.

Provide FCF Margin
for XOMA Corp.

Show all solvency ratios
for XOMA Corp.

Provide D/E Ratio
for XOMA Corp.

Provide D/A Ratio
for XOMA Corp.

Provide Interest Coverage Ratio
for XOMA Corp.

Provide Altman Z-Score Ratio
for XOMA Corp.

Provide Quick Ratio
for XOMA Corp.

Provide Current Ratio
for XOMA Corp.

Provide Cash Ratio
for XOMA Corp.

What is the historical Revenue growth
over the last 5 years for XOMA Corp?

What is the historical Net Income growth
over the last 5 years for XOMA Corp?

What is the current Free Cash Flow
of XOMA Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for XOMA Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
XOMA Corp

Current Assets 159m
Cash & Short-Term Investments 142.8m
Receivables 13.7m
Other Current Assets 2.5m
Non-Current Assets 64.3m
PP&E 369k
Other Non-Current Assets 64m
Current Liabilities 21.1m
Accounts Payable 1.1m
Accrued Liabilities 2.9m
Other Current Liabilities 17.1m
Non-Current Liabilities 117.4m
Long-Term Debt 108.1m
Other Non-Current Liabilities 9.3m
Efficiency

Earnings Waterfall
XOMA Corp

Revenue
23.1m USD
Operating Expenses
-41.9m USD
Operating Income
-18.8m USD
Other Expenses
-23.6m USD
Net Income
-42.4m USD

Free Cash Flow Analysis
XOMA Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

XOMA Profitability Score
Profitability Due Diligence

XOMA Corp's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative 3-Years Revenue Growth
Declining ROE
24/100
Profitability
Score

XOMA Corp's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

XOMA Solvency Score
Solvency Due Diligence

XOMA Corp's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
38/100
Solvency
Score

XOMA Corp's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XOMA Price Targets Summary
XOMA Corp

Wall Street analysts forecast XOMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XOMA is 84.66 USD with a low forecast of 49.49 USD and a high forecast of 122.85 USD.

Lowest
Price Target
49.49 USD
58% Upside
Average
Price Target
84.66 USD
171% Upside
Highest
Price Target
122.85 USD
293% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for XOMA?

Click here to dive deeper.

Dividends

XOMA Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for XOMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

XOMA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

XOMA Corp Logo
XOMA Corp

Country

United States of America

Industry

Biotechnology

Market Cap

367.5m USD

Dividend Yield

0%

Description

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. The company is headquartered in Emeryville, California and currently employs 12 full-time employees. The firm's drug royalty aggregator business is focused on early to mid-stage clinical assets primarily in Phase I and II. XOMA acquires pre-commercial therapeutic candidates that are licensed to pharmaceutical or biotechnology companies. The firm's portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. The firm's royalty-aggregator business includes acquiring additional licenses to programs with third-party funding and has more than 70 assets. XOMA royalty portfolio includes NIS793, anti-transforming growth factor-beta (TGFb) antibody program; gevokizumab (VPM087); mezagitamab (TAK-079), iscalimab (CFZ533), and MK-4830.

Contact

CALIFORNIA
Emeryville
2200 Powell St Ste 310
+15102047239.0
www.xoma.com

IPO

1986-06-06

Employees

12

Officers

CEO & Director
Mr. Owen P. Hughes Jr.
Senior VP of Finance & CFO
Mr. Thomas M. Burns
Chief Investment Officer
Mr. Brad Sitko

See Also

Discover More
What is the Intrinsic Value of one XOMA stock?

The intrinsic value of one XOMA stock under the Base Case scenario is 35.65 USD.

Is XOMA stock undervalued or overvalued?

Compared to the current market price of 31.26 USD, XOMA Corp is Undervalued by 12%.

Back to Top